Study of ISB 1342, a CD38/CD3 Bispecific Antibody, in Subjects With Previously Treated Multiple Myeloma
Clinical trial NCT03309111 · COMPLETED
Trial details
- NCT number
- NCT03309111
- Sponsor
- Ichnos Sciences SA
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-25
- Primary completion
- 2023-12-15
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.